Release Date: 05/07/22 09:11 Summary: ASX Notice - Admission and Commencement of Trading Price Sensitive: No Download Document 517.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%